Online Inquiry
Cat.#: ACPP-1695
| Despition | LGALS9 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1036 | Recombinant Human ANGPTL7 Protein (6×His Tag) (AC1036) | 50 µg | inquiry |
| ACPP-1275 | Usherin Blocking Peptide (AC1275) | 250 µg | inquiry |
| ACPP-1343 | GIRK1 Blocking Peptide (AC1343) | 250 µg | inquiry |
| ACPP-1688 | Human CDK1 Protein, Sf9 (AC1688) | 2 µg | inquiry |
| ACPP-1176 | Recombinant Human GRPR Protein (Fc Tag) (AC1176) | 50 µg | inquiry |
| ACPP-1428 | Mouse LGALS7 Protein (AC1428) | 5 µg | inquiry |
| ACPP-1465 | Human CHRNA3 Protein (AC1465) | 5 µg | inquiry |
| ACPP-1458 | Mouse LGALS3 Protein (AC1458) | 2 µg | inquiry |
| ACPP-1080 | GABA B Receptor 2 Blocking Peptide (AC1080) | 250 µg | inquiry |
| ACPP-1414 | Human BEX1 Protein (AC1414) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.